ArticleMethods in molecular biology (Clifton, N.J.)2026
Bioinformatics Analysis of Bc3, IL-8, and PD-L1 Gene Co-expression in Glioblastoma and Pan-Cancer Using Xena Platform.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anti-Glioma Agents and Hyperbaric Oxygen for Prospective Therapeutic Approaches.International journal of molecular sciences · 2026Review
- PD-L1 in Ovarian Cancer: Immune Evasion, Tumor-Intrinsic Signaling, and Chemoresistance.Cancer medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Identification of key genes regulating critical cellular functions, such as cancer cell proliferation, invasion, and immune escape, is essential for the development of novel cancer therapeutic targets and patient stratification. Our studies have shown that the expression of the proto-oncogene Bcl3 and the pro-angiogenic chemokine IL-8 is increased in ovarian cancer (OC) tissues and correlates with the expression of immune checkpoint PD-L1, resulting in increased proliferation of OC cells. Here, we describe a protocol to analyze the gene co-expression of Bcl3, IL-8, and PD-L1 by using the Xena platform and show that Bcl3, IL-8, and PD-L1 are co-expressed in glioblastoma as well as in pan-cancer samples.
Indexed as
Identifiers
41478995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.